Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review).

Abstract

INTRODUCTION Pharmacology and immunology of botulinum toxin. Botulinum neurotoxin (BoNT) is a microbial protein that exists in seven serotypes, designated A through G. Although the individual serotypes are immunologically distinct, all members of the group possess similar subunit structures, act on the same target organs, and produce similar functional… (More)
DOI: 10.1212/WNL.0b013e3181af0b6e

Topics

Cite this paper

@article{Simpson2009AssessmentBN, title={Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review).}, author={David M. Simpson and Jean-Michel Gracies and Kathryn A. Graham and Mark Hallett and Janis M. Miyasaki and Markus K Naumann and B A Russman and Lance Simpson and Yuen Tat So}, journal={Neurology}, year={2009}, volume={73 9}, pages={736-7; author reply 737-8} }